Call for Papers

21^st Century Cures Act: A Cure for the 21^st Century?

In the most recent major, bipartisan-passed bill, Congress enacted substantial changes to the biotechnology industry. Prompted by public outcry over price and access to pharmaceuticals, as well as industry pressure to alleviate regulatory constraints, the 21st Century Cures Act purports to both tackle hindrances in the biotechnological space and drive drug and device innovation. The goal, it seems, is to reinvigorate the pharmaceutical/device industry, while promoting access to these products — but can this bill accomplish such goals? What lies ahead for consumers and the industry?

The American Journal of Law and Medicine (AJLM) will hold its annual symposium on Friday, January 26, 2018. Our symposium is an opportunity for interdisciplinary scholars/professionals to share and publish their knowledge on the given topic. This year’s topic is: 21^st Century Cures Act: A Cure for the 21^st Century? Accepted papers will be published in our summer 2018 Symposium Edition and presented at the symposium in Boston. This is an open call for papers from any academic perspective, including, but not limited to, law, public health, medicine, economics, bioethics, business, and history.

Please send a one-page abstract, as well as complete contact information and resume/CV, to ajlm@bu.edu by Monday, October 16, 2017. Selected authors for presentation and publication will be notified by Friday, October 27, 2017. Full-length articles should be submitted by January 19, 2018, for inclusion in the Symposium Edition. Completed articles must be no longer than 7,000 words, include citations, and must touch on some aspect of the 21^st Century Cures Act. AJLM pays for reasonable travel expenses of invited authors.